- New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
-
Kim K, Ginsberg HN, Choi SH
- KMID: 2533651
- Diabetes Metab J.
- 2022 Sep;46(5):817-818.
- doi: 10.4093/dmj.2022.0295
-
- CITED
-
- Close
- SHARE
-
- Close
- New, Novel Lipid-Lowering Agents for Reducing Cardiovascular Risk: Beyond Statins
-
Kim K, Ginsberg HN, Choi SH
- KMID: 2531956
- Diabetes Metab J.
- 2022 Jul;46(4):517-532.
- doi: 10.4093/dmj.2022.0198
Statins are the cornerstone of the prevention and treatment of atherosclerotic cardiovascular disease (ASCVD). However, even under optimal statin therapy, a significant residual ASCVD risk remains. Therefore, there has been... -
- CITED
-
- Close
- SHARE
-
- Close
